Swelling Ganges opens up India’s riverside graves

By Ritesh Shukla and Saurabh Sharma

PRAYAGRAJ, India (Reuters) – More corpses are washing up on the banks of the Ganges in India’s most populous state of Uttar Pradesh, as rains swell the river and expose bodies buried in shallow graves during the peak of the country’s latest wave of coronavirus infections.

Videos and pictures in May of bodies drifting down the river, which Hindus consider holy, shocked the nation and underlined the ferocity of the world’s biggest surge in infections.

Though cases have come down drastically this month, the Uttar Pradesh city of Prayagraj alone has cremated 108 bodies found in the river in the last three weeks, said a senior municipal official.

“These are those dead bodies which were buried very close to the river and have gone into it with the rise in its water levels,” Neeraj Kumar Singh told Reuters.

“The municipal corporation has deployed a team of 25 people who are working day and night on this front.”

Reuters saw more than a dozen riverside pyres burning a few miles from Prayagraj.

India, the world’s second most populous country, saw its health infrastructure crushed in April and May. Hospitals ran out of beds and life-saving oxygen and crematoriums became overwhelmed with the dead.

The government of Uttar Pradesh, home to 240 million people, acknowledged in May that bodies of COVID-19 victims were being dumped into rivers in a practice likely stemming from poverty and families abandoning victims for fear of the disease.

“Instructions have been passed to every district magistrate to cremate the dead bodies with proper respect,” said Uttar Pradesh government spokesperson Navneet Sehgal.

“There are dead bodies buried on the river bank and it is because of a local tradition.”

The state reported 224 COVID-19 infections overnight, taking its total caseload to 1.7 million, while total fatalities are at 22,366.

(Reporting by Ritesh Shukla in Prayagraj, Saurabh Sharma in Lucknow and Uday Sampath in Bengaluru; editing by Jonathan Oatis)

Exclusive-India’s most populous state to spend up to $1.36 billion on COVID shots amid shortage

By Krishna N. Das

NEW DELHI (Reuters) -India’s most populous state will spend up to $1.36 billion to buy COVID-19 shots and held early talks this week with companies such as Pfizer and the local partner of the maker of Russia’s Sputnik V, a state official said on Thursday.

The move by Uttar Pradesh, home to more people than Brazil, comes as many Indian states curtail vaccinations due to severe shortages amid a record surge in coronavirus infections, with India recording more than 4,000 deaths for a second straight day as its health system fails to cope.

Uttar Pradesh has also held pre-bid talks with Indian vaccine companies the Serum Institute of India (SII) – licensed to make the AstraZeneca and Novavax shots – Bharat Biotech and Cadila Healthcare as part of a global tender to buy 40 million doses over the next few months, state spokesman Navneet Sehgal told Reuters.

He said Johnson & Johnson could also confirm their participation in the tender by late Thursday via email. Sputnik V’s local distributor, Dr. Reddy’s Laboratories, has also held talks.

“Money is not an issue, we have a huge budget,” said Sehgal, a senior bureaucrat in the state of 240 million people. “We will spend up to 100 billion rupees ($1.36 billion).”

He said funds would have to be diverted from other areas to buy the vaccines.

Dr. Reddy’s and Bharat Biotech declined to comment. Pfizer, J&J, SII and Cadila did not immediately respond to requests for comment.

Uttar Pradesh has also separately ordered 10 million doses of the AstraZeneca vaccine and Bharat Biotech’s Covaxin.

“WHERE IS ‘INDIA’?”

Prime Minister Narendra Modi opened vaccinations to all adults from May 1, doubling the number of people eligible to an estimated 800 million, though domestic production will stay largely flat at about 80 million a month until July.

The result is that several states now plan to launch global supply tenders individually. Reuters earlier reported that the federal government would not import vaccines itself.

“Indian states left to compete/fight with each other in international market,” Delhi Chief Minister Arvind Kejriwal said on Twitter.

“Where is ‘India’? Portrays such a bad image of India. India, as one country, should procure vaccines on behalf of all Indian states.”

Modi’s office and the health ministry did not respond to requests for comment.

COVID-19 immunizations in the country in the past week have hit levels last seen in mid-March when India did fewer than 2 million doses a day and vaccinations were limited to only health and front-line workers.

The country has administered nearly 179 million doses, the most after China and the United States, but has given the required two doses to only 3% of its 1.35 billion people.

Vinod Kumar Paul, a top government official leading India’s response to the pandemic, told a news briefing vaccine supplies would improve significantly from August. He said more than 2 billion locally made doses may be available between August and December.

That includes 750 million doses of the AstraZeneca vaccine and 200 million of Novavax, both via SII. Others include 156 million doses of Sputnik V and shots developed by Indian companies such as Biological E.

(Reporting by Krishna N. Das; Additional reporting by Aishwarya Nair, Tanvi Mehta, Shilpa Jamkhandikar, Anuron Kumar Mitra and Sumit Khanna; Editing by Nick Macfie and Catherine Evans)